Claims
- 1. A method for administering a sterilant to a wild animal, comprising:(a) providing a ballistic projectile containing an effective amount of a sterilant; (b) providing a weapon capable of receiving said ballistic projectile and of firing said projectile toward said wild animal, said projectile or a companion projectile fired simultaneously therewith, comprising a means for marking said animal such that said animal can be identified as being hit by said projectile, said weapon having a recording means operatively associated therewith to record the image of said animal; (c) firing said projectile into the muscle tissue of an animal, such sterilant being effective to either permanently or temporarily sterilize the animal.
- 2. The method of claim 1, wherein said pellet comprises from about 45% to a 97% by weight of said sterilant.
- 3. A system for providing a sterilant or medicant to wild animals, comprising:a ballistic projectile containing an effective amount of a sterilant or medicant; a weapon capable of receiving said ballistic projectile and firing said projectile towards said wild animal; said weapon having a recording means operatively associated therewith to record the image of said animal; and wherein said projectile or companion projectile fired simultaneously comprises a means for marking said animal such that said animal can be identified as being hit by said projectile.
- 4. The method as set forth in claim 1 wherein said sterilant is selected from the group consisting of steroids, hormone toxin conjugates, GnRH agonists, and GnRH antagonists.
- 5. The method as set forth in claim 1 wherein said projectile comprises an agent known to inhibit the hypothalamic-pituitary-gonadal axis.
- 6. The method as set forth in claim 1 wherein said sterilant comprises a hormone toxin conjugate comprising a peptide hormone capable of selectively binding to cells having GnRH receptors, said conjugate capable of destroying cells expressing said receptors.
RELATED APPLICATION
This application claims priority from U.S. Provisional Patent Application No. 60/093,087 filed on Jul. 16, 1998 and from abandoned U.S. Pat. Application Ser. No. 07/314,653, filed Feb. 23, 1989 and related issued U.S. Pat. Nos. 5,378,688; 5,631,229; 5,707,964; 5,492,893; 5,488,036; 5,786,457; 6,103,881 and 6,326,467. The entire disclosure of the above applications and registrations are considered to be part of the disclosure of the accompanying application and are hereby incorporated by reference.
US Referenced Citations (18)
Foreign Referenced Citations (3)
Number |
Date |
Country |
0450461 |
Oct 1991 |
EP |
2185486 |
Jul 1987 |
GB |
WO 9009799 |
Sep 1990 |
WO |
Non-Patent Literature Citations (6)
Entry |
Ballistivet Vaccine Delivery System Advertisement—2 pages. |
Ballistivet Vaccine Delivery System Advertisement -2 pages. |
Szepeshzi et al., Anti-Cancer Drugs, 3 109-116 (1992). |
Proc, Nat'l, Acad. Sci, Bajusz et al., vol. 86, pp. 6318-6322, (Aug. 1989). |
Peptides, Proceedings of the Sixth American Pept. Symposium, E. Gross and J. Heienhofer (eds.), pp. 803-806. |
U.S. Patent Application No. 07/314,653, filed Feb. 23, 1989. |
Provisional Applications (1)
|
Number |
Date |
Country |
|
60/093087 |
Jul 1998 |
US |